0.00Open0.00Pre Close0 Volume0 Open Interest1.50Strike Price0.00Turnover0.00%IV-20.00%PremiumJan 17, 2025Expiry Date0.25Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.92Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Rani Therapeutics Stock Discussion
Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
No comment yet